Search Tag: device implantation
2015 30 Aug
In a Hot Line presentation at the ESC Congress in London, investigators reported the findings from the LEADLESS II study which showed that a leadless cardiac pacemaker demonstrated good safety and reliable function during the initial six months of follow-up. The findings have been published in the New England Journal of Medicine. The study shows...Read more
2015 25 Jun
The European Society of Cardiology (ESC) has recommended uninterrupted anticoagulation with vitamin K antagonists during ablation and device implantation in a position paper presented at EHRA EUROPACE – CARDIOSTIM 2015 and published in EP Europace. “Antithrombotic management in patients undergoing electrophysiology procedures’ was produced by the...Read more